Regeneron Pharmaceuticals, Inc. Announces Upcoming 2013 Investor Conference Presentations
Published: Nov 01, 2013
TARRYTOWN, N.Y., Nov. 1, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:
- Credit Suisse 2013 Healthcare Conference at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time) on Tuesday, November 12, 2013
- Deutsche Bank 2013 BioFEST at 1:05 p.m. Eastern Time on Monday, December 2, 2013
- Piper Jaffray 25th Annual Healthcare Conference at 8:30 a.m. Eastern Time on Tuesday, December 3, 2013
The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.
Manisha Narasimhan, Ph.D.
SOURCE Regeneron Pharmaceuticals, Inc.
Help employers find you! Check out all the jobs and post your resume.